Citations

Mayo Clinic

Showing 10 of 108599 citations.

Thirty-day postoperative morbidity and mortality after temporal lobectomy for medically refractory epilepsy
Kerezoudis, Panagiotis , McCutcheon, Brandon A., Murphy, Meghan E. , Rajjoub, Kenan , Ubl, Daniel S. , Habermann, Elizabeth B. , Bydon, Mohamad , McCutcheon, Brandon, Ubl, Daniel, Worrell, Gregory A. , Gompel, Jamie J. Van , Habermann, Elizabeth

Journal of Neurosurgery | June 23, 2017 | Volume: 128 | Issue: 4 | Pages: 1158-1164

10.3171/2016.12.jns162096 | PMID 28644097 Get It

OBJECTIVETemporal lobectomy is a well-established treatment modality for the management of medically refractory epilepsy in appropriately selected patients. The aim of this study was to assess 30-day morbidity and mortality after temporal lobectomy in cases registered in a national database.METHODSA retrospective cohort analysis was conducted using a multiinstitutional surgical registry compiled between 2006 and 2014. The authors identified patients who underwent anterior temporal lobectomy and/or amygdalohippocampectomy for a primary diagnosis of intractable epilepsy. Univariate and multivariable analyses with regard to patient demographics, comorbidities, operative characteristics, and 30-day outcomes were applied.RESULTSA total of 216 patients were included in the study. The median age was 38 years and 46% of patients were male. The median length of stay was 3 days and the 30-day mortality rate was 1.4%. Fourteen patients (6.5%) developed at least one major complication. Return to the operating room was observed in 7 patients (3.2%). Readmission within 30 days and discharge to a location other than home were available for 2011–2014 (n = 155) and occurred in 11% and 10.3% of patients, respectively. Multivariable regression analysis revealed that increasing age was an independent predictor of discharge disposition other than home and that male sex was a significant risk factor for the development of a major complication. Interestingly, the presence of the attending neurosurgeon and a resident during the procedure was significantly associated with decreased odds of prolonged length of stay (i.e., > 75th percentile [5 days]) and discharge to a location other than home.CONCLUSIONSUsing a multiinstitutional surgical registry, 30-day outcome data after temporal lobectomy for medically intractable epilepsy demonstrates a mortality rate of 1.4%, a major complication rate of 6.5%, and a readmission rate of 11%. Temporal lobectomy is an extremely effective therapy for seizures originating there—however, surgical intervention must be weighed against its morbidity and mortality outcomes.
Young Athletes After Anterior Cruciate Ligament Reconstruction With Single-Leg Landing Asymmetries at the Time of Return to Sport Demonstrate Decreased Knee Function 2 Years Later
Ithurburn, Matthew P. , Paterno, Mark V. , Ford, Kevin R. , Hewett, Timothy E. , Schmitt, Laura C.

The American Journal of Sports Medicine | June 23, 2017 | Volume: 45 | Issue: 11 | Pages: 2604-2613

10.1177/0363546517708996 | PMID 28644677 Get It

Background: Previous work shows that young athletes after anterior cruciate ligament reconstruction (ACLR) demonstrate single-leg (SL) landing movement asymmetries at the time of return to sport (RTS); however, the effect of movement asymmetries on longitudinal knee-related function after ACLR has not been examined. Hypothesis/Purpose: The purpose of this study was to examine the effect of SL drop-landing movement symmetry at the time of RTS on knee-related function 2 years later in young athletes after ACLR. The first hypothesis was that young athletes who demonstrated SL drop-landing asymmetries at RTS would demonstrate decreased knee function 2 years later compared with those who demonstrated symmetric SL drop-landing mechanics. The second hypothesis was that SL drop-landing movement symmetry at RTS would be associated with knee functional recovery 2 years later. Study Design: Cohort study; Level of evidence, 2. Methods: This study included 48 young athletes who had undergone ACLR and were assessed at the time of RTS (77% female; mean [±SD] age at RTS, 17.6 ± 2.6 years) and followed for 2 years after RTS. Three sagittal-plane landing variables of interest were calculated using 3-dimensional motion analysis during an SL drop-landing task at the time of RTS: knee flexion excursion, peak internal knee extension moment, and peak trunk flexion. The limb symmetry index (LSI) was calculated for each landing variable using the following: LSI = (involved/uninvolved) × 100%. The LSI was used to divide the cohort into symmetric (SYM) and asymmetric (ASYM) groups for each landing variable: knee flexion excursion (SYM: LSI ≥ 90% [n = 23]; ASYM: LSI < 85% [n = 18]), peak internal knee extension moment (SYM: LSI ≥ 90% [n = 19]; ASYM: LSI < 85% [n = 22]), and peak trunk flexion (SYM: LSI ≤ 105% [n = 25]; ASYM: LSI > 115% [n = 19]). At 2 years after RTS, knee-related function was evaluated using the Knee Injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC) subjective knee form, and performance on SL hop tests. Functional recovery was defined based on literature cutoffs for knee-related functional measures. Differences in 2-year function were compared between the symmetry groups using Mann-Whitney U tests because of nonnormality. Logistic regression was used to determine if landing symmetry at the time of RTS would be associated with 2-year knee functional recovery after RTS. Results: The ASYM knee flexion excursion group demonstrated decreased function at 2 years after RTS compared with the SYM group on the KOOS-Pain (ASYM: 93.0 ± 8.2; SYM: 98.4 ± 3.0; P = .008) and the KOOS–Quality of Life (ASYM: 81.6 ± 16.1; SYM: 94.1 ± 9.7; P = .008). Knee flexion excursion was associated with knee functional recovery on the KOOS-Pain and the KOOS–Quality of Life ( P = .033 and P = .012, respectively) at 2 years after RTS, after controlling for the quadriceps strength LSI and graft type. Conclusion: Young athletes after ACLR with asymmetries in knee kinematics at the time of RTS reported decreased self-reported function 2 years later; however, the clinical importance of these differences needs to be further understood.
ECG-based 4D-dose reconstruction of cardiac arrhythmia ablation with carbon ion beams: application in a porcine model
Eichhorn, Anna, Constantinescu, A., Kaderka, Robert, Prall, Matthias, Lugenbiel, Patrick , Takami, Mitsuru , Thomas, Dierk , Bert, Christoph , Packer, Douglas L. , Graeff, Christian , Lehmann, H. Immo , Bert, Christoph , Durante, Marco , Graeff, Christian , Richter, Daniel , Prall, M. W., Durante, Marco

Physics in Medicine & Biology | June 23, 2017 | Volume: 62 | Issue: 17 | Pages: 6869-6883

10.1088/1361-6560/aa7b67 | PMID 28644151 Get It

Abstract Noninvasive ablation of cardiac arrhythmia by scanned particle radiotherapy is highly promising, but especially challenging due to cardiac and respiratory motion. Irradiations for catheter-free ablation in intact pigs were carried out at the GSI Helmholtz Center in Darmstadt using scanned carbon ions. Here, we present real-time electrocardiogram (ECG) data to estimate time-resolved (4D) delivered dose. For 11 animals, surface ECGs and temporal structure of beam delivery were acquired during irradiation. R waves were automatically detected from surface ECGs. Pre-treatment ECG-triggered 4D-CT phases were synchronized to the R – R interval. 4D-dose calculation was performed using GSI’s in-house 4D treatment planning system. Resulting dose distributions were assessed with respect to coverage ( D 95 and V 95), heterogeneity (HI = D 5– D 95) and normal tissue exposure. Final results shown here were performed offline, but first calculations were started shortly after irradiation The D 95 for TV and PTV was above 95% for 10 and 8 out of 11 animals, respectively. HI was reduced for PTV versus TV volumes, especially for some of the animals targeted at the atrioventricular junction, indicating residual interplay effects due to cardiac motion. Risk structure exposure was comparable to static and 4D treatment planning simulations. ECG-based 4D-dose reconstruction is technically feasible in a patient treatment-like setting. Further development of the presented approach, such as real-time dose calculation, may contribute to safe, successful treatments using scanned ion beams for cardiac arrhythmia ablation.
Faculty Opinions recommendation of Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
Kaufmann, Scott H. , Yun, Seongseok

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 23, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727620770.793533377 Get It

Low leptin concentration may identify heart failure patients with central sleep apnea
Čundrle, Ivan , Singh, Prachi , Johnson, Bruce D. , Olson, Lyle J. , Olson, Lyle J , Somers, Virend K. , Scott, Christopher G. , Singh, Prachi , Cundrle, Ivan

Journal of Sleep Research | June 23, 2017 | Volume: 27 | Issue: 2 | Pages: 240-243

10.1111/jsr.12574 | PMID 28643476 Get It

SummaryLow leptin concentration has been shown to be associated with central sleep apnea in heart failure patients. We hypothesized that low leptin concentration predicts central sleep apnea. Consecutive ambulatory New York Heart Association (NYHA) classes I–IV heart failure patients were studied prospectively, including measurement of serum leptin, echocardiography and polysomnography. Sleep apnea was defined by type (central/mixed/obstructive) and by apnea–hypopnea index ≥5 by polysomnography. Subjects were divided into four groups by polysomnography: (1) central sleep apnea, (2) mixed apnea, (3) no apnea and (4) obstructive sleep apnea. Fifty‐six subjects were included. Eighteen subjects were diagnosed with central sleep apnea, 15 with mixed apnea, 12 with obstructive apnea and 11 with no sleep apnea. Leptin concentration was significantly lower in central sleep apnea compared to obstructive apnea (8 ± 10.7 ng mL−1 versus 19.7 ± 14.7 ng mL−1, P ˂ 0.01) or no sleep apnea (8 ± 10.7 ng mL−1 versus 17.1 ± 8.4 ng mL−1, P ˂ 0.01). Logistic regression showed leptin to be associated independently with central sleep apnea [odds ratio (OR): 0.19; 95% confidence interval (CI): 0.06–0.62; area under the curve (AUC): 0.80, P < 0.01]. For the detection of central sleep apnea, a cut‐off value for leptin concentration 5 ng mL−1 yielded a sensitivity of 50% and specificity of 89%. In conclusion, a low leptin concentration may have utility for the screening of heart failure patients for central sleep apnea.
A Neuropsychiatric Analysis of the Cotard Delusion
Sahoo, Aradhana, Josephs, Keith A.

The Journal of Neuropsychiatry and Clinical Neurosciences | June 23, 2017 | Volume: 30 | Issue: 1 | Pages: 58-65

10.1176/appi.neuropsych.17010018 | PMID 28641497 Get It

The effect of concomitant fields in fast spin echo acquisition on asymmetric MRI gradient systems
Tao, Shengzhen , Weavers, Paul T., Trzasko, Joshua D. , Shu, Yunhong , Gray, Erin M. , Foo, Thomas , Bernstein, Matt A. , Bernstein, Matt A , Huston, John , Foo, Thomas K F

Magnetic Resonance in Medicine | June 23, 2017 | Volume: 79 | Issue: 3 | Pages: 1354-1364

10.1002/mrm.26789 | PMID 28643408 Get It

PurposeTo investigate the effect of the asymmetric gradient concomitant fields (CF) with zeroth and first‐order spatial dependence on fast/turbo spin‐echo acquisitions, and to demonstrate the effectiveness of their real‐time compensation.MethodsAfter briefly reviewing the CF produced by asymmetric gradients, the effects of the additional zeroth and first‐order CFs on these systems are investigated using extended‐phase graph simulations. Phantom and in vivo experiments are performed to corroborate the simulation. Experiments are performed before and after the real‐time compensations using frequency tracking and gradient pre‐emphasis to demonstrate their effectiveness in correcting the additional CFs. The interaction between the CFs and prescan‐based correction to compensate for eddy currents is also investigated.ResultsIt is demonstrated that, unlike the second‐order CFs on conventional gradients, the additional zeroth/first‐order CFs on asymmetric gradients cause substantial signal loss and dark banding in fast spin‐echo acquisitions within a typical brain‐scan field of view. They can confound the prescan correction for eddy currents and degrade image quality. Performing real‐time compensation successfully eliminates the artifacts.ConclusionsWe demonstrate that the zeroth/first‐order CFs specific to asymmetric gradients can cause substantial artifacts, including signal loss and dark bands for brain imaging. These effects can be corrected using real‐time compensation. Magn Reson Med 79:1354–1364, 2018. © 2017 International Society for Magnetic Resonance in Medicine.
Effects of Intensive BP Control in CKD
CHEUNG, ALFRED K., Rahman, Mahboob, Reboussin, David M. , Craven, Timothy E., Greene, Tom, Pl, Kimmel, Hawfield, Amret , Johnson, Karen , Lewis, Cora E., Oparil, S, Rocco, Michael V., Sink, Kaycee M. , Pk, Whelton, Wright, Jackson T., Jn, Basile, Bhatt, Udayan, Chertow, Glenn M., Chonchol, M, Freedman, Barry I., Haley, William, Ix, J H, Katz, Lois A., Killeen, Anthony A. , Ricardo, Ana C., Servilla, Karen, Wall, Barry, Wolfgram, Dawn, Yee, Jerry , Chertow, Glenn M. , Greene, Tom , Rocco, Michael V. , Rahman, Mahboob , Craven, Tim, Cushman, William C. , Lewis, Cora E. , Beddhu, Srinivasan , Bhatt, Udayan, Chang, Tara I. , Chonchol, Michel , Freedman, Barry I. , Haley, William E. , Ix, Joachim H. , Katz, Lois Anne , Papademetriou, Vasilios , Servilla, Karen S. , Wolfgram, Dawn F. , Greene, Tom , Rocco, Michael V

Journal of the American Society of Nephrology | June 22, 2017 | Volume: 28 | Issue: 9 | Pages: 2812-2823

10.1681/asn.2017020148 | PMID 28642330 Get It

The appropriate target for BP in patients with CKD and hypertension remains uncertain. We report prespecified subgroup analyses of outcomes in participants with baseline CKD in the Systolic Blood Pressure Intervention Trial. We randomly assigned participants to a systolic BP target of <120 mm Hg (intensive group; n =1330) or <140 mm Hg (standard group; n =1316). After a median follow-up of 3.3 years, the primary composite cardiovascular outcome occurred in 112 intensive group and 131 standard group CKD participants (hazard ratio [HR], 0.81; 95% confidence interval [95% CI], 0.63 to 1.05). The intensive group also had a lower rate of all-cause death (HR, 0.72; 95% CI, 0.53 to 0.99). Treatment effects did not differ between participants with and without CKD ( P values for interactions ≥0.30). The prespecified main kidney outcome, defined as the composite of ≥50% decrease in eGFR from baseline or ESRD, occurred in 15 intensive group and 16 standard group participants (HR, 0.90; 95% CI, 0.44 to 1.83). After the initial 6 months, the intensive group had a slightly higher rate of change in eGFR (−0.47 versus −0.32 ml/min per 1.73 m 2 per year; P <0.03). The overall rate of serious adverse events did not differ between treatment groups, although some specific adverse events occurred more often in the intensive group. Thus, among patients with CKD and hypertension without diabetes, targeting an SBP<120 mm Hg compared with <140 mm Hg reduced rates of major cardiovascular events and all-cause death without evidence of effect modifications by CKD or deleterious effect on the main kidney outcome.
Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2
Dieffenbach, Paul B., Haeger, Christina Mallarino, Coronata, Anna Maria F., Choi, Kyoung Moo , Varelas, Xaralabos , Tschumperlin, Daniel J. , Fredenburgh, Laura E. , Varelas, Xaralabos

American Journal of Physiology-Lung Cellular and Molecular Physiology | June 22, 2017 | Volume: 313 | Issue: 3 | Pages: L628-L647

10.1152/ajplung.00173.2017 | PMID 28642262 Get It

Pulmonary arterial stiffness is an independent risk factor for mortality in pulmonary hypertension (PH) and plays a critical role in PH pathophysiology. Our laboratory has recently demonstrated arterial stiffening early in experimental PH, along with evidence for a mechanobiological feedback loop by which arterial stiffening promotes further cellular remodeling behaviors (Liu F, Haeger CM, Dieffenbach PB, Sicard D, Chrobak I, Coronata AM, Suárez Velandia MM, Vitali S, Colas RA, Norris PC, Marinković A, Liu X, Ma J, Rose CD, Lee SJ, Comhair SA, Erzurum SC, McDonald JD, Serhan CN, Walsh SR, Tschumperlin DJ, Fredenburgh LE. JCI Insight 1: e86987, 2016). Cyclooxygenase-2 (COX-2) and prostaglandin signaling have been implicated in stiffness-mediated regulation, with prostaglandin activity inversely correlated to matrix stiffness and remodeling behaviors in vitro, as well as to disease progression in rodent PH models. The mechanism by which mechanical signaling translates to reduced COX-2 activity in pulmonary vascular cells is unknown. The present work investigated the transcriptional regulators Yes-associated protein (YAP) and WW domain-containing transcription regulator 1 (WWTR1, a.k.a., TAZ), which are known drivers of downstream mechanical signaling, in mediating stiffness-induced changes in COX-2 and prostaglandin activity in pulmonary artery smooth muscle cells (PASMCs). We found that YAP/TAZ activity is increased in PAH PASMCs and experimental PH and is necessary for the development of stiffness-dependent remodeling phenotypes. Knockdown of YAP and TAZ markedly induces COX-2 expression and downstream prostaglandin production by approximately threefold, whereas overexpression of YAP or TAZ reduces COX-2 expression and prostaglandin production to near undetectable levels. Together, our findings demonstrate a stiffness-dependent YAP/TAZ-mediated positive feedback loop that drives remodeling phenotypes in PASMCs via reduced COX-2 and prostaglandin activity. The ability to interrupt this critical mechanobiological feedback loop and enhance local prostaglandin activity via manipulation of YAP/TAZ signaling presents a highly attractive novel strategy for the treatment of PH.